Fonteyne Paul R.
- SEC CIK
- 0001727550
No open-market purchases or sales filed in the past year.
Current role at each company
- APMD Apnimed, Inc.Directoras of Aug 3, 2026
- AMLX Amylyx Pharmaceuticals, Inc.Directoras of Jun 8, 2026
- APLS Apellis Pharmaceuticals, Inc.Directoras of May 14, 2026
- CVET Covetrus, Inc.Directoras of Oct 13, 2022
- GLSH Gelesis Holdings, Inc.Directoras of May 9, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Fonteyne Paul R. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AMLX Amylyx Pharmaceuticals, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 10, 2022 (view filing) | Jan 6 | 4 days | Fonteyne Paul R.Director | PPurchase | +3.95K | $19.00 | +$75.0K | New position3.95K after |
CVET Covetrus, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2021 (view filing) | Aug 10 | 1 day | Fonteyne Paul R.Director | PPurchase | +5.00K | $23.24 | +$116.2K | New position5.00K after |